Margaret Echerd - 30 Nov 2021 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
01 Dec 2021, 15:05:52 UTC
Prior SEC filing
13 Sep 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Margaret Echerd

Key filing fact

Margaret Echerd filed Form 4 for Vaxart, Inc. (VXRT) on 01 Dec 2021.

Key facts

  • This page summarizes Margaret Echerd's Form 4 filing for Vaxart, Inc. (VXRT).
  • 5 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 01 Dec 2021, 15:05.

Change

  • Previous filing in this sequence was filed on 13 Sep 2021.
  • Current net transaction value: -$23,112.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VXRT transaction

Common Stock

Options Exercise

Transaction value
$3,443
Shares
+666
Change %
Price
$5.17*
Shares after
666
Date
30 Nov 2021
Ownership
Direct
VXRT transaction

Common Stock

Options Exercise

Transaction value
$2,261
Shares
+2,936
Change %
+441%
Price
$0.7700
Shares after
3,602
Date
30 Nov 2021
Ownership
Direct
VXRT transaction

Common Stock

Sale

Transaction value
$28,816
Shares
-3,602
Change %
-100%
Price
$8.00*
Shares after
0
Date
30 Nov 2021
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VXRT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-666
Change %
-29%
Price
$0.000000
Shares after
1,667
Date
30 Nov 2021
Ownership
Direct
Underlying class
Common stock
Underlying amount
666
Exercise price
$5.17
Footnotes
F2
VXRT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-2,936
Change %
-10%
Price
$0.000000
Shares after
26,416
Date
30 Nov 2021
Ownership
Direct
Underlying class
Common stock
Underlying amount
2,936
Exercise price
$0.7700
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.

Footnote F2

The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of April 9, 2018, and the remaining shares in 36 equal monthly installments thereafter.

Footnote F3

The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares in 36 equal monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .